Immunotherapy for fungal infections

Area of Science:

• Medical Mycology
• Immunology
• Infectious Diseases

Background:

• Opportunistic fungal infections pose a significant threat, leading to high morbidity and mortality in immunocompromised individuals.
• Fungi exhibit complex survival strategies within the host, adapting to environmental stressors like nutrient scarcity, pH changes, and reactive oxygen/nitrogen species, while evading host immune responses.

Purpose of the Study:

• To explore the immunopathogenesis of fungal infections.
• To highlight promising immunotherapy strategies for managing these infections in immunocompromised hosts.
• To discuss challenges in translating these therapies into clinical practice.

Main Methods:

• Review of current literature on fungal survival mechanisms and host-pathogen interactions.
• Analysis of established and emerging immunotherapy approaches.
• Discussion of clinical translation hurdles.

Main Results:

• Fungal adaptation to host stressors and immune evasion are critical factors in infection.
• Immunotherapies targeting phagocyte enhancement, innate pathway activation, and antigen-specific immunity show promise.
• Tailoring immunotherapy to specific immunocompromised states is essential for efficacy.

Conclusions:

• Knowledge of fungal immunopathogenesis provides a foundation for novel immunotherapy development.
• Successful clinical application of immunotherapies requires addressing challenges in laboratory-to-clinic translation.
• Personalized immunotherapy strategies are crucial for combating opportunistic fungal infections.